Notice NOT-MD-20-028 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-20-055 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research to improve understanding of the evolutionary dynamics of seasonal influenza to increase our capacity to predict the emergence of new antigenic variants and more accurately select strains for use in the seasonal influenza vaccine.

Funding Opportunity RFA-DK-20-505 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application for the Scientific Data Research Center (SDRC) of the Gastroparesis Clinical Research Consortium (GpCRC). The companion FOA, RFA-DK-20-504 will support continuation of the GpCRC Clinical Centers (CC). The Consortium forms a multi-disciplinary teams composed of members from the CCs and SDRC to undertake a comprehensive clinical, epidemiological and biological characterization of adult and children patients with GP to gain insight into the pathophysiology of GP and its sequela: chronic abdominal pain, nausea and vomiting, poor metabolic control and impaired quality of life. To achieve the goal of a comprehensive characterization of evolving Gastroparesis both in diabetic and non-diabetic patients, as well as in children the Scientific Data Research Center (SDRC) will take on the administrative and data collection/analysis functions and will be responsible for the conduct of all of the ongoing and future studies of the CCs In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of bio-specimens (blood stools and when feasible gastric tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection as well as to build on the ongoing Pathological Basis of gastroparesis study which will increase understanding of the pathological basis of gastroparesis.

Notice NOT-HL-20-817 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-038 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-20-504 from the NIH Guide for Grants and Contracts. The primary purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to invite applications from the clinical sites that have participated in the NIDDK Gastroparesis Clinical Research Consortium (GPRCR), to support the ongoing GPCRC cohorts, including the first U.S. registry of children and adolescents with gastroparesis, to support ongoing clinical trials and to provide a platform for informative ancillary studies. In addition, a major collaborative effort within the Consortium will be the establishment of an annotated repository of bio-specimens (blood stools and when feasible gastric tissue) to allow for the identification and validation of biomarkers for risk stratification and/or early detection as well as to build on the ongoing Pathological Basis of gastroparesis study which will increase understanding of the pathological basis of gastroparesis.

Notice NOT-MD-20-030 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-312 from the NIH Guide for Grants and Contracts. The primary purpose of this Funding Opportunity Announcement (FOA) is to solicit meritorious applications for the continuity and expansion of existing state occupational safety and health surveillance programs and the development of new programs, with the goal of improving surveillance across the US.

Notice NOT-AG-20-052 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-009 from the NIH Guide for Grants and Contracts

Minimum yearly (gross) salary of € 32,000 on a full time base: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: The Winter laboratory at CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences in.... Vienna, Austria

Competitive Salary: EMBL: Human Trait Curator Location: EM Cambridge, Cambridgeshire, England

Notice NOT-NS-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-HL-20-015 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-20-702 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. RFA-MH-20-701uses the R01 grant mechanism whileRFA-MH-20-702uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data may wish to apply using the R01 mechanism.

Up to £60,000 plus benefits and share options: Singular Talent: Expert in Genomics and Immunology? Want to get involved in some genuinely novel science targeting autoimmune diseases? Take a look at this..... Oxford, Oxfordshire (GB)

Competitive Salary: EMBL: Computer scientist/data analyst in Single Cell Genomics & Imaging data Germany (DE)

Notice NOT-DA-20-081 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-107 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-20-046 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and the risk factors for infection. Such studies should inform and advance efforts to reduce or eliminate KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of developing HIV infection.